$2.5T
Total marketcap
$60.64B
Total volume
BTC 50.19%     ETH 16.09%
Dominance

Genovis AB (publ.) GENO.ST Stock

30.4 SEK {{ price }} -1.618123% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
1.99B SEK
LOW - HIGH [24H]
29.5 - 31.75 SEK
VOLUME [24H]
99.9K SEK
{{ volume }}
P/E Ratio
36.62
Earnings per share
0.83 SEK

Genovis AB (publ.) Price Chart

Genovis AB (publ.) GENO.ST Financial and Trading Overview

Genovis AB (publ.) stock price 30.4 SEK
Previous Close 52.9 SEK
Open 52.9 SEK
Bid 52.3 SEK x 0
Ask 52.6 SEK x 0
Day's Range 52.4 - 53.1 SEK
52 Week Range 31.15 - 71.8 SEK
Volume 9.38K SEK
Avg. Volume 75.51K SEK
Market Cap 3.44B SEK
Beta (5Y Monthly) 1.701149
PE Ratio (TTM) 76.08696
EPS (TTM) 0.83 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 82 SEK

GENO.ST Valuation Measures

Enterprise Value 3.44B SEK
Trailing P/E 76.08696
Forward P/E 12.209302
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 24.158983
Price/Book (mrq) 20.215633
Enterprise Value/Revenue 24.175
Enterprise Value/EBITDA 68.865

Trading Information

Genovis AB (publ.) Stock Price History

Beta (5Y Monthly) 1.701149
52-Week Change 14.00%
S&P500 52-Week Change 20.43%
52 Week High 71.8 SEK
52 Week Low 31.15 SEK
50-Day Moving Average 57.4 SEK
200-Day Moving Average 50.29 SEK

GENO.ST Share Statistics

Avg. Volume (3 month) 75.51K SEK
Avg. Daily Volume (10-Days) 73.1K SEK
Shares Outstanding 65.47M
Float 55.1M
Short Ratio N/A
% Held by Insiders 18.51%
% Held by Institutions 45.04%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 29.83%
Operating Margin (ttm) 33.07%
Gross Margin 88.94%
EBITDA Margin 35.10%

Management Effectiveness

Return on Assets (ttm) 17.12%
Return on Equity (ttm) 28.57%

Income Statement

Revenue (ttm) 142.26M SEK
Revenue Per Share (ttm) 2.17 SEK
Quarterly Revenue Growth (yoy) 118.79%
Gross Profit (ttm) 88.54M SEK
EBITDA 49.94M SEK
Net Income Avi to Common (ttm) 42.44M SEK
Diluted EPS (ttm) 0.69
Quarterly Earnings Growth (yoy) 253.69%

Balance Sheet

Total Cash (mrq) 115.4M SEK
Total Cash Per Share (mrq) 1.76 SEK
Total Debt (mrq) 6.4M SEK
Total Debt/Equity (mrq) 3.77 SEK
Current Ratio (mrq) 7.773
Book Value Per Share (mrq) 2.597

Cash Flow Statement

Operating Cash Flow (ttm) 47.05M SEK
Levered Free Cash Flow (ttm) 29.85M SEK

Profile of Genovis AB (publ.)

Country Sweden
State N/A
City Lund
Address Scheelevägen 2
ZIP 220 07
Phone 46 46 10 12 30
Website https://www.genovis.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 37

Genovis AB (publ.) designs, develops, and sells tools for development of new treatment methods and diagnostics for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, and generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; GingisKHAN, a cysteine protease that digests human IgG1; and FabDELLO, a protease that digests human IgG1. In addition, the company offers GingisREX, a cysteine protease that specifically digests peptide bonds C-terminally; GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology for site-specific and quantitative conjugation of IgG; TransGLYCIT, a platform technology that enables site-specific human IgG glycan remodeling; OmniGLYZOR, a mixture of immobilized enzymes; PNGase F, a glycoamidase hydrolyzing the amide bond between the polypeptide asparagine and the innermost GlcNAc; and OpeRATOR, an O-glycan-specific protease. Further, it provides OglyZOR, an endoglycosidase; SialEXO, a sialidase product; FucosEXO, a mix of a-Fucosidases; GalactEXO, a ß-Galactosidase mix; GalNAcEXO, an a-N-Acetylgalactosaminidase; GlycOCATCH, an affinity resin for purification of mucin-type O-glycosylated proteins and peptides; GlycINATOR (EndoS2), an IgG-specific endoglycosidase; IgGZERO (EndoS), an IgG-specific endoglycosidase; Anti-FabRICATOR (Anti-IdeS), a goat polyclonal antibody; and Anti-FabRICATOR Z (Anti-IdeZ), a goat polyclonal antibody, as well as operates online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Sweden, Europe, North America, and Asia. Genovis AB (publ.) was founded in 1999 and is based in Lund, Sweden.

Q&A For Genovis AB (publ.) Stock

What is a current GENO.ST stock price?

Genovis AB (publ.) GENO.ST stock price today per share is 30.4 SEK.

How to purchase Genovis AB (publ.) stock?

You can buy GENO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Genovis AB (publ.)?

The stock symbol or ticker of Genovis AB (publ.) is GENO.ST.

Which industry does the Genovis AB (publ.) company belong to?

The Genovis AB (publ.) industry is Biotechnology.

How many shares does Genovis AB (publ.) have in circulation?

The max supply of Genovis AB (publ.) shares is 65.47M.

What is Genovis AB (publ.) Price to Earnings Ratio (PE Ratio)?

Genovis AB (publ.) PE Ratio is 36.62650700 now.

What was Genovis AB (publ.) earnings per share over the trailing 12 months (TTM)?

Genovis AB (publ.) EPS is 0.83 SEK over the trailing 12 months.

Which sector does the Genovis AB (publ.) company belong to?

The Genovis AB (publ.) sector is Healthcare.

Genovis AB (publ.) GENO.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden SEK GI FNSESEKGI 1956.89 SEK 191.02 USD
-0.28
First North Sweden EUR GI FNSEEURGI 1570.14 EUR 1716.38 USD
-0.77
First North 25 FN25 2021.27 EUR 2209.52 USD
-1.13
First North Health Care GI FN20GI 917.04 EUR 1002.44 USD
-1.17
First North All-Share EUR FIRSTNORTHEUR 97.9 EUR 107.01 USD
-0.64
First North Sweden SEK PI FNSESEKPI 1843.91 SEK 179.99 USD
-0.28
First North Sweden EUR PI FNSEEURPI 1479.5 EUR 1617.29 USD
-0.77
First North 25 GI FN25GI 2138.56 EUR 2337.74 USD
-1.08
First North Health Care PI FN20PI 912.9 EUR 997.92 USD
-1.17
First North All-Share SEK FIRSTNORTHSEK 123.34 SEK 12.04 USD
-0.14
First North All-Share DKK FIRSTNORTHDKK 97.96 DKK 14.36 USD
-0.62